Eye Allergy Treatment Market Scope And Analysis

Eye Allergy Treatment Market Report Scope

Industry Developments and Future Opportunities:

A few initiatives taken by market players operating in the global eye allergy treatment market are listed below:

• In September 2020, Dr Reddy's Laboratories launched an over-the-counter eye allergy drop, Olopatadine Hydrochloride Ophthalmic Solution, in the US market. The solution is indicated to temporarily relieve itchy eyes due to pollen, grass, animal hair, and dander.
• In February 2020, Alcon received Food and Drug Administration approval for Pataday’s once-daily relief and Pataday’s twice-daily relief for over-the-counter sale in the US. The Pataday brand features the No. 1 doctor-prescribed eye allergy itch relief ingredient and includes the first once-daily allergy itch relief drop to be available without a prescription.

Competitive Landscape and Key Companies:

The eye allergy treatment market forecast can help stakeholders plan their growth strategies. Bausch + Lomb, Alcon, AbbVie, Johnson & Johnson, Akorn Inc., Nicox, Santen Pharmaceutical Co. Ltd, Teva Pharmaceutical Industries Ltd, Novartis AG, and Sun Pharmaceutical Industries Ltd. are among the prominent players in the market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.